Periodic acceleration: Effects on vasoactive, fibrinolytic, and coagulation factors

Journal of Applied Physiology

Volumn 98, Issue 3, 2005, Pages 1083-1090

  Adams, Jose A ^a   Bassuk, Jorge ^a   Wu, Dongmei ^a   Grana, Maria ^a   Kurlansky, Paul ^b   Sackner, Marvin A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Florida Heart Research Institute   (United States)

Author keywords

Endothelin; Endothelium; Nitric oxide; Prostaglandins; Pulsatile shear stress

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR; D DIMER; HYDROCORTISONE; NITRIC OXIDE; NITRITE; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ARTICLE; ASSISTED VENTILATION; BLOOD CLOTTING; BODY MOVEMENT; BREATHING; CARDIOPULMONARY HEMODYNAMICS; CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM; FIBRINOLYSIS; LAMINAR FLOW; NONHUMAN; PERIODIC ACCELERATION; PRIORITY JOURNAL; PULSATILE FLOW; RANDOMIZATION; SHEAR STRESS; SWINE;

ACCELERATION; ANIMALS; BLOOD COAGULATION FACTORS; FIBRINOLYTIC AGENTS; MOVEMENT; PERIODICITY; PHYSICAL STIMULATION; SHEAR STRENGTH; STRESS, MECHANICAL; SWINE; VASODILATOR AGENTS;

EID: 14144251094     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00662.2004     Document Type: Article

References (55)

1. Adams JA, Mangino MJ, Bassuk J, Inman DM, and Sackner MA. Noninvasive motion ventilation (NIMV): a novel approach to ventilatory support. J Appl Physiol 89: 2438-2446, 2000.
2. Adams JA, Mangino MJ, Bassuk J, Kurlansky P, and Sackner MA. Regional blood flow during periodic acceleration. Crut Care Med 29: 1983-1988, 2001.
3. z acceleration in meconium aspiration in pigs. J Appl Physiol 89: 2447-2452, 2000.
4. Adams JA, Moore JE Jr, Moreno MR, Coelho J, Bassuk J, and Wu D. Effects of periodic body acceleration on the in vivo vasoactive response to N-ω-nitro-L-arginine and the in vitro nitric oxide production. Ann Biomed Eng 31: 1337-1346, 2003.
5. 2 by vascular smooth muscle cells. Biochem Biophys Res Commun 224: 808-814, 1996.
6. Ballermann BJ, Dardik A, Eng E, and Liu A. Shear stress and the endothelium. Kidney Int Suppl 67: S100-S108, 1998.
7. Bergsdorf N, Nilsson T, and Wallen P. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Haemost 50: 740-744, 1983.
8. Berkels R, Purol-Schnabel S, and Roesen R. A new method to measure nitrate/nitrite with a NO-sensitive electrode. J Appl Physiol 90: 317-320, 2001.
9. Cadroy Y, Pillard F, Sakariassen KS, Thalamas C, Boneu B, and Riviere D. Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers. J Appl Physiol 93: 829-833, 2002.
10. Canty JMJ and Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 89: 375-384, 1994.
11. Coplan NL, Gleim GW, and Nicholas JA. Exercise-related changes in serum catecholamines and potassium: effect of sustained exercise above and below lactate threshold. Am Heart J 117: 1070-1075, 1989.
12. Creminon C, Frobert Y, and Habib A. Enzyme immunometric assay for endothelin using tandem monoclonal antibodies. J Immunol Methods 162: 179-192, 1993.
13. Cuzzolin L, Lussignoli S, Crivellente F, Adami A, Schena F, Bellavite P, Brocco G, and Benoni G. Influence of an acute exercise on neutrophil and platelet adhesion, nitric oxide plasma metabolites in inactive and active subjects. Int J Sports Med 21: 289-293, 2000.
14. Davidge ST, Baker PN, Laughlin MK, and Roberts JM. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283, 1995.
15. Doroudi R, Gan LM, Selin SL, and Jern S. Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model. Biochem Biophys Res Commun 269: 257-264, 2000.
16. El Sayed MS. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation. Sports Med 22: 282-298, 1996.
17. Eriksson E, Ranby M, and Gyzand E. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single point poly-D-lysine stimulated assay. Thromb Res 50: 91-101, 1988.
18. Esch T, Stefano G, Fricchione G, and Benson H. Stress-related diseases -a potential role for nitric oxide. Med Sci Monit 8: RA103-RA118, 2002.
19. Fong KL, Crysler CS, Mico BA, Boyle KE, Kopia GA, Kopaciewicz L, and Lynn RK. Dose-dependent pharmacokinetics of recombinant tissue-type plasminogen activator in anesthetized dogs following intravenous infusion. Drug Metab Dispos 16: 201-206, 1988.
20. Froloch JC. Measurement of eicosanoids. Prostaglandins 27: 349-369, 1984.
21. Gardiner C, Mackie IJ, and Machin SJ. Evaluation of a new automated latex particle immunoassay for D-dimer: IL Test™ D-dimer. Laborat Hematol 6: 147-150, 1999.
22. Hamberg M and Samelsson B. On the metabolism of prostaglandins E1 and E2 in man. J Biol Chem 246: 6713-6721, 1971.
23. Handa K, Terao Y, Mori T, Tanaka H, Kiyonaga A, Matsunaga A, Sasaki J, Shindo M, and Arakawa K. Different coagulability and fibrinolytic activity during exercise depending on exercise intensities. Thromb Res 66: 613-616, 1992.
24. Hegde SS, Goldfarb AH, and Hegde S. Clotting and fibrinolytic activity change during the 1 h after a submaximal run. Med Sci Sports Exerc 33: 887-892, 2001.
25. Hoover GN, Ashe WF, Dines JH, and Fraser TM III. Vibration studies: blood pressure responses to whole-body vibration in anesthetized dogs. Arch Environ Health 3: 426-432, 1961.
26. Hutcheson IR and Griffith TM. Release of endothelium-derived relaxing factor is modulated by both frequency and amplitude of pulsatile flow. Am J Physiol Heart Circ Physiol 261: H257-H262, 1991.
27. Jungersten L, Ambring A, Wall B, and Wennmalm A. Both physical fitness and acute exercise regulate nitric oxide formation in healthy humans. J Appl Physiol 82: 760-764, 1997.
28. Kaijser L, Nowak J, Patrono C, and Wennmalm A. Release of prostacyclin into the coronary venous blood in patients with coronary arterial disease. Adv Myocardiol 4: 371-378, 1983.
29. Kelm M, Preik-Steinhoff H, Preik M, and Strauer BE. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res 41: 765-772, 1999.
30. Korninger C. Sandwich ELISA for t-PA antigen employing a monoclonal antibody. Thromb Res 41: 535, 1986.
31. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, and Kelm M. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad Sci USA 98: 12814-12819, 2001.
32. Legnani C. Performance of a new, fast D-dimer test (IL Test TM D-dimer) for the management of outpatients with suspected DVT in emergency situations. Fibrinol Proteol 13: 139-141, 1999.
33. Masaki T and Yanagisawa M. Endothelins. Essays Biochem 27: 79-89, 1992.
34. Nelson SL, Hynd BA, and Pickrum HM. Automated enzyme immunoassay to measure prostaglandin E2 in gingival crevicular fluid. J Periodontal Res 27: 143-148, 1992.
35. Newby DE, Wright RA, Dawson P, Ludlam CA, Boon NA, Fox KA, and Webb DJ. The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res 38: 485-492, 1998.
36. Niess AM, Sommer M, Schlotz E, Northoff H, Dickhuth HH, and Fehrenbach E. Expression of the inducible nitric oxide synthase (iNOS) in human leukocytes: responses to running exercise. Med Sci Sports Exerc 32: 1220-1225, 2000.
37. Node K, Kitakaze M, Sato H, Koretsune Y, Katsube Y, Karita M, Kosaka H, and Hori M. Effect of acute dynamic exercise on circulating plasma nitric oxide level and correlation to norepinephrine release in normal subjects. Am J Cardiol 79: 526-528, 1997.
38. Palatini P, Mos L, Mormino P, Di Marco A, Munari L, Fazio G, Giuliano G, Pessina AC, and Dal Palu C. Blood pressure changes during running in humans: the "beat" phenomenon. J Appl Physiol 67: 52-59, 1989.
39. Pedersen BK and Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80: 1055-1081, 2000.
40. Rassaf T, Kleinbongard P, Preik M, Dejam A, Gharini P, Lauer T, Erckenbrecht J, Duschin A, Schulz R, Keusch G, Feelisch M, and Keim M. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ Res 91: 470-477, 2002.
41. Rijken DO. Measurement of human tissue-type plasminogen activator by a two site immunoradiometric assay. J Lab Clin Med 1983.
42. Rogers KM, Bonar CA, Estrella JL, and Yang S. Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am J Physiol Heart Circ Physiol 283: H1922-H1928, 2002.
43. Rosenkranz B, Fisher C, and Reimann I. Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1alpha in man. Biochim Biophys Acta 619: 207-213, 1980.
44. Rubio AR and Morales-Segura MA. Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control. Arch Med Res 35: 1-11, 2004.
45. Shimoda LA, Norins NA, and Madden JA. Responses to pulsatile flow in piglet isolated cerebral arteries. Pediatr Res 43: 514-520, 1998.
46. Sjogren LS, Gan L, Doroudi R, Jern C, Jungersten L, and Jern S. Fluid shear stress increases the intra-cellular storage pool of tissue-type plasminogen activator in intact human conduit vessels. Thromb Haemost 84: 291-298, 2000.
47. Soler M, Camacho M, Escudero JR, Iniguez MA, and Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res 87: 504-507, 2000.
48. St Croix CM, Wetter TJ, Pegelow DF, Meyer KC, and Dempsey JA. Assessment of nitric oxide formation during exercise. Am J Respir Crit Care Med 159: 1125-1133, 1999.
49. Stefano GB, Prevot V, Cadet P, and Dardik I. Vascular pulsations stimulating nitric oxide release during cyclic exercise may benefit health: a molecular approach (review). Int J Mol Med 7: 119-129, 2001.
50. Taguchi I, Ogawa K, Oida A, Abe S, Kaneko N, and Sakio H, Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol 86: 1139-4111, A9, 2000.
51. Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, and Koehler E. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J 20: 1493-1502, 1999.
52. Toyota E, Goto M, Nakamoto H, Ebata J, Tachibana H, Hiramatsu O, Ogasawara Y, and Kajiya F. Endothelium-derived nitric oxide enhances the effect of intraaortic balloon pumping on diastolic coronary flow. Ann Thorac Surg 67: 1254-1261, 1999.
53. Vassalle C, Lubrano V, L'Abbate A, and Clerico A. Determination of nitrite plus nitrate and malondialdehyde in human plasma: analytical performance and the effect of smoking and exercise. Clin Chem Lab Med 40: 802-809, 2002.
54. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 56: 577-581, 1996.
55. Zhang X and Broderick M. Amperometric detection of nitric oxide. Mod Asp Immunobiol 4: 160-165, 2000.